The vasoactive potential of kisspeptin-10 in the peripheral vasculature

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Sawyer, Iain ^a   Smillie, Sarah Jane ^a   Bodkin, Jennifer V ^a   Fernandes, Elizabeth ^a   O'Byrne, Kevin T ^b   Brain, Susan D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; ENDOTHELIN 1; KISSPEPTIN 10; MESSENGER RNA; SUBSTANCE P; ANTIHISTAMINIC AGENT; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; G PROTEIN COUPLED RECEPTOR; INDOMETACIN; KISS1 PROTEIN, HUMAN; KISS1R PROTEIN, MOUSE; KISSPEPTIN; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EDEMA; EXTRAVASATION; FEMALE; GENE; GENE EXPRESSION; HEART; HYPERTENSION; KIDNEY; KISSPEPTIN PEPTIDE GENE; KISSPEPTIN RECEPTOR GENE; MALE; MOUSE; NONHUMAN; PERIPHERAL CIRCULATION; PLASMA CLEARANCE; SKIN BLOOD FLOW; SKIN BLOOD VESSEL; VASOCONSTRICTION; ANIMAL; ANTIBODY SPECIFICITY; CHEMICALLY INDUCED DISORDER; CIRCULATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MICROVASCULATURE; PALLOR; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; BLOOD CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; ENDOTHELIN-1; FEMALE; GENE EXPRESSION REGULATION; HISTAMINE ANTAGONISTS; HUMANS; INDOMETHACIN; KISSPEPTINS; MALE; MICE; MICROVESSELS; ORGAN SPECIFICITY; PALLOR; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SUBSTANCE P; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 79951779174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014671     Document Type: Article

References (42)

1. Dungan HM, Clifton DK, Steiner RA, (2006) Minireview: Kisspeptin Neurons as Central Processors in the Regulation of Gonadotropin-Releasing Hormone Secretion. Endocrinology 147: 1154-1158.
2. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, et al. (1996) KiSS-1, a Novel Human Malignant Melanoma Metastasis-Suppressor Gene. J Natl Cancer Inst 88: 1731-1737.
3. Cho SG, Li D, Stafford LJ, Luo J, Rodriguez-Villanueva M, et al. (2009) KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-Mediated NF-kappaB activation. J Cell Biochem 107: 1139-1149.
4. Bilban M, Ghaffari-Tabrizi N, Hintermann E, Bauer S, Molzer S, et al. (2004) Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 117: 1319-1328.
5. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, et al. (2003) The GPR54 Gene as a Regulator of Puberty. N Engl J Med 349: 1614-1627.
6. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain J-L, et al. (2003) Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. PNAS 100: 10972-10976.
7. Messager S, Chatzidaki EE, Ma D, Hendrick AG, Zahn D, et al. (2005) Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. PNAS 102: 1761-1766.
8. Irwig MS, Fraley GS, Smith JT, Acohido BV, Popa SM, et al. (2004) Kisspeptin Activation of Gonadotropin Releasing Hormone Neurons and Regulation of KiSS-1 mRNA in the Male Rat. Neuroendocrinology 80: 264-272.
9. Li XF, Kinsey-Jones JS, Cheng Y, Knox AM, Lin Y, et al. Kisspeptin signalling in the hypothalamic arcuate nucleus regulates GnRH pulse generator frequency in the rat. PLoS One 2009 16;4 (12): e8334.
10. Cho SG, Yi Z, Pang X, Yi T, Wang Y, et al. (2009) Kisspeptin-10, a KISS1-Derived Decapeptide, Inhibits Tumor Angiogenesis by Supressing Sp-1-Mediated VEGF Expression and FAK/Rho GTPase Activation. Cancer Res 69: 7062-7070.
11. Mead EJ, Maguire JJ, Kuc RE, Davenport AP, (2007) Kisspeptins Are Novel Potent Vasoconstrictors in Humans, with a Discrete Localization of Their Receptor, G Protein-Coupled Receptor 54, to Atherosclerosis-Prone Vessels. Endocrinology 148: 140-147.
12. Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, et al. (2003) Dramatic Elevation of Plasma Metastin Concentrations in Human Pregnancy: Metastin as a Novel Placenta-Derived Hormone in Humans. J Clin Endocrinol Metab 88: 914-919.
13. Zhang J, Meikle S, Trumble A, (2003) Severe Maternal Morbidity Associated with Hypertensive Disorders in Pregnancy in the United States. Hypertens Pregnancy 22: 203-212.
14. Qiao C, Wang CH, Shang T, Lin QD, (2005) Clinical significance of KiSS-1 and matrix metalloproteinase-9 expression in trophoblasts of women with preeclampsia and their relation to perinatal outcome of neonates. Zhonghua Fu Chan Ke Za Zhi 40: 585-590.
15. Armstrong RA, Reynolds RM, Leask R, Shearing CH, Calder AA, et al. (2009) Decreased serum levels of Kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia. Prenat Diagns 29: 982-985.
16. Brain SD, Williams TJ, (1985) Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharm 86: 855-860.
17. Brain SD, Tippins JR, Williams TJ, (1988) Endothelin induces potent microvascular constriction. Br J Pharm 95: 1005-1007.
18. Santic R, Schmidhuber SM, Lang R, Rauch I, Voglas E, et al. (2007) Alarin is a vasoactive peptide. PNAS 104: 10217-10222.
19. Cao T, Gerard NP, Brain SD, (1999) Use of NK1 knockout mice to analyze substance P-induced edema formation. Am J Physiol Regul Integr Comp Physiol 277: R476-481.
20. Wei J-F, Wei X-L, Mo Y-Z, He S-H, (2009) Induction of mast call accumulation, histamine release and skin edema by N49 phospholipase A2. BMC Immunol.
21. Schmidhuber SM, Santic R, Tam CW, Bauer JW, Kofler B, et al. (2006) Galanin-Like Peptides Exert Potent Vasoactive Functions In Vivo. J Invest Dermatol 127: 716-721.
22. Liang L, Tam CW, Pozsgai G, Siow R, Clark N, et al. (2009) Protection of Angiotensin II-Induced Vascular Hypertrophy in Vascular Smooth Muscle-Targeted Receptor Activity-Modifying Protein 2 Transgenic Mice. Hypertension 54: 1254-1261.
23. Johar S, Cave AC, Narayanapanicker A, Grieve DJ, Shah AM, (2006) Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J 20: 1546-1548.
24. Hauge-Evans A, Richardson C, Milne H, Christie M, Persaud S, et al. (2006) A role for kisspeptin in islet function. Diabetologia 49: 2131-2135.
25. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clin Chem 55: 611-622.
26. Owen DAA, Pipkin MA, Woodward DF, (1984) Studies on cutaneous vascular permeability in the rat: Increases caused by histamine and histamine-like agents. Inflammation Research 14: 39-42.
27. Roseweir AK, Kauffman AS, Smith JT, Guerriero KA, Morgan K, et al. (2009) Discovery of Potent Kisspeptin Antagonists Delineate Physiological Mechanisms of Gonadotropin Regulation. J Neurosci 29: 3920-3929.
28. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
29. Mead EJ, Maguire JJ, Kuc RE, Davenport AP, (2007) Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. British Journal of Pharmacology 151: 1143-1153.
30. Repke H, Piotrowski W, Bienert M, Foreman JC, (1987) Histamine release induced by Arg-Pro-Lys-Pro(CH2)11CH3 from rat peritoneal mast cells. J Pharmacol Exp Ther 243: 317-321.
31. Brain SD, Cox HM, (2005) Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol =147: S202-S211.
32. Kobayashi T, Sasaki S, Tomita N, Fukui S, Kuroda N, et al. (2010) Synthesis and structure-activity relationships of 2-acylamino-4,6-diphenylpyridine derivatives as novel antagonists of GPR54. Bioorg Med Chem 18: 3841-3859.
33. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden J-M, et al. (2001) The Metastasis Suppressor Gene KiSS-1 Encodes Kisspeptins, the Natural Ligands of the Orphan G Protein-coupled Receptor GPR54. J Biol Chem 276: 34631-34636.
34. Wilson DP, Susnjar M, Kiss E, Sutherland C, Walsh MP, (2005) Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697. Biochem J 389: 763-774.
35. Shen R-F, Tai H-H, (1998) Thromboxanes: Synthase and Receptors. J Biomed Sci 5: 153-172.
36. Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, et al. (2001) AXOR12, a Novel Human G Protein-coupled Receptor, Activated by the Peptide KiSS-1. J BiolChemy 276: 28969-28975.
37. Kim S, Iwao H, (2000) Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases. Pharmacol Rev 52: 11-34.
38. Nijher GM, Chaudhri OB, Ramachandran R, Murphy KG, Zac-Varghese SE, et al. The effects of kisspeptin-54 on blood pressure in humans and plasma Kp-10 concentrations in hypertensive diseases of pregnancy. Br J Clin Pharmacol 2010 70 (5): 674-81.
39. Yi T, Tan K, Cho S-G, Wang Y, Luo J, et al. (2010) Regulation of Embryonic Kidney Branching Morphogenesis and Glomerular Development by KISS1 Receptor (Gpr54) through NFAT2- and Sp1-mediated Bmp7 Expression. J Biol Chem 285: 17811-17820.
40. Bytautiene E, Vedernikov YP, Saade GR, Romero R, Garfield RE, (2008) The Effect of a Mast Cell Degranulating Agent on Vascular Resistance in the Human Placental Vascular Bed and on the Tone of Isolated Placental Vessels. Reprod Sci 15: 26-32.
41. Carole AO, Wei Z, Hae-Ki M, Han-Zhang X, Andrea P, et al. (2005) Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J Allergy Clin Immunol 115: 1162-1168.
42. Curtis AE, Cooke JH, Baxter JE, Parkinson JRC, Bataveljic A, et al. (2010) A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10. Am J Physiol Endocrinol Metab 298: E296-303.